Go back

2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one

Print | Download PDF

Basic Chemical Information

CAT No.# CS-AB-00070
Category Impurities
CAS 141745-36-0
Stock Status
AVAILABLE ENQUIRE NOW

(Available within 1-2 Weeks)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.

Specification

Molecular Weight 402.49
Molecular Formula C23H26N6O
Purity >98%
Synonyms 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one

Storage & Shipping*

Shipping:
Free Shipping worldwide for orders above 2000 USD*.

Related Results

for '2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one'

- API Standards of Losartan

- Stable Isotopes of Losartan

- Metabolites of Losartan

- Impurities of Losartan

- Glucuronides of Losartan

- Intermediates of Losartan

Page info:

This page contains information about 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one Cas 141745-36-0 and its Impurities.

2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2 Worldwide Suppliers of 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one Impurities Clearsynth 141745-36-0

2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one Worldwide Suppliers of 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one Impurities Clearsynth CS-AB-00070

Product rating: 9 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one based on 20 ratings

  1. Impurities
  2. 2-Butyl-3,5-dihydro-5,5-dimethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Imidazol-4-one

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."